Marco Vitolo Ⓜ️
@marcovitoloMD
Followers
451
Following
951
Media
171
Statuses
782
MD, PhD, FESC • Assistant Professor at UNIMORE | Cardiologist 🩺 | Honorary Research Fellow-LCCS | Associate #SoMe Editor #Europace 💻| Tweets are my own
Modena, Emilia Romagna
Joined February 2020
🚨 New Controversy out in #Europace! 🫀 The blanking period after AF ablation 🎯 🎙️ Watch the interview between #Europace EiC and EHRA President 👉 Read the Controversy on Europace https://t.co/oYJVcnvOj5
1
13
33
📣 Live from #ESCCongress2025 in Madrid 📺 Watch the interview by @DavideMei93 with Prof. Boersma on the results of the FARADISE Registry just published on #Europace 📚Read the full article https://t.co/All3pSCPsP ✒️ Editorial https://t.co/f0vwljG6dU
0
7
13
The results of our Late Breaking Presentation at #ESCCongress2025 are now published on EJPC! @escardio
Simultaneous publication during #ESCCongress Heart Failure in Patients with Recently Diagnosed Atrial Fibrillation: Findings from the GLORIA-AF Registry Phase III - https://t.co/WsdzCnfNHe
#EAPC_ESC #EJPC
0
4
12
🚨 Simultaneous #ESCCongress2025 publication! ⚡️FARADISE Global Registry: 1-year clinical effectiveness of PFA for AF Presented by Prof. Lucas Boersma 📊See full results 👉 https://t.co/All3pSCPsP 📚Read the accompanying editorial https://t.co/YDvEGRTpnx
1
22
50
Simultaneous publication during #ESCCongress Heart Failure in Patients with Recently Diagnosed Atrial Fibrillation: Findings from the GLORIA-AF Registry Phase III - https://t.co/WsdzCnfNHe
#EAPC_ESC #EJPC
1
16
72
#ESCCongress Cost-effectiveness of Apixaban vs ASS for the Reduction of Thrombo-Embolism in High-Risk Patients with DDAF: Insights from the ARTESiA trial 📖 https://t.co/FfJnrgPo02
@GiulioConte @FraSantoroMD @marcovitoloMD
@Dominik_Linz @DavideMei93 @AndyZhangMD
@LuigiDiBiaseMD
0
7
20
🖼️ Our traditional family portrait at the #ESCCongress2025 Honored to be part of this fantastic international research team 🇮🇹🇬🇧🇪🇸 Exciting projects ahead @BorianiGiuseppe @LiverpoolCCS @JacopoImberti @DavideMei93 @GiulioFRomiti @B_Corica @MProiettiMD @_martamantovani @escardio
0
5
13
📣Fantastic #ESCCongress2025 packed session on AF, frailty & multimorbidity! 🌍 Brilliantly chaired by Prof. Lip & Prof. Potpara, highlighting the vital role of integrated, holistic management to improve patient outcomes👏 #AFib❣️ @GiulioFRomiti @simovicst @LiverpoolCCS
1
6
11
📣 Live from #ESCCongress2025 in Madrid: @EuropaceEiC and @joselmerino talking on the new EHRA Practical Compendium on AADs 🫀✨ 📚A must-read for clinicians in arrhythmia management! Read the full paper 🔗 https://t.co/F6aqqDRNbF
#Europace #EPeeps
@EHRAPresident @escardio
2
21
48
🆕 New publication in EHJ-QCCO! Check out the results on the association between Female sex👩, AF, OAC use, residual stroke risk, and CHA₂DS₂-VA vs CHA₂DS₂-VASc in a large European cohort 💊🧠 🔗 Full text link https://t.co/y6pYjSvtQT
@BorianiGiuseppe @LiverpoolCCS
1
5
9
📣 From #ESCcongress: Prof @MatteoBertini5 presents the TREEBEARD studyjust out in #Europace 👥 344 pts <65y 📉 LBBAP vs RVP ↓ composite endpoint at 2y (6.3% vs 12.7%, HR 0.78) ❤️ ↓ HF hosp. (HR 0.79) 🔎 Subgroups consistent 👉 Open access https://t.co/eg4Zb35WeB
0
8
13
Our registry-based RCT is out now with a simultaneous publication on @EuropaceEiC! LBBAP ↓ CV mortality or HF hosp As comparef w/ RVP in young adults <65y at 2-yrs follow-up 🖇️ https://t.co/hjBpNhTcFe
@escardio @MatteoBertini5
0
5
12
📢 #LateBreakingTrial @ESCCongress2025 LBBAP vs RVP in young adults – Italian registry 🇮🇹 👥 4911 screened | 344 <65y ⏱ 2-year FU ✅ LBBAP ↓ CV mortality + HF hosp. ➡️ Strongest benefit in young pts with AV block @escardio @simovicst @GawalkoMonika @PriyaPBK @Dominik_Linz
1
20
46
📢Simultaneous pubblication now out in #Europace Prof @MatteoBertini5 presented the results of LBBAP vs RV pacing in middle aged adults using a registry-based trial Chek out the results of the analysis and the full open access text 🔗 https://t.co/jSBq2Lmeft
0
11
20
🚀 First day at #ESCCongress2025 ❣️ Great start with the Europace Editorial Board Meeting – thank you to all for the amazing work! 📣Stay tuned for simultaneous publications & all the latest updates ➡️ follow @EuropaceEiC and our SOME Editors ✨ Visit 🌐 https://t.co/iEbCY3sXJc
0
7
12
First Day at #ESCCongress2025 ❤️🚀 Hola Madrid 🇪🇸! @JacopoImberti @DavideMei93 @GiulioFRomiti @B_Corica @escardio
0
2
9
📣 New publication alert! The ESC–EHRA Atlas of Cardiology has just been published in @EuropaceEiC! 🌍 It provides the most comprehensive overview of cardiac electrophysiology across Europe and beyond — thanks to the contributions of national cardiac societies 🙏 Huge thanks
0
28
82
#Europace #Epeeps ⚡️Different underlying aetiologies in patients with #VT fulfilling TFC for #ARVC: initial suspicion based on ECG 📑 https://t.co/QWpl5wFEJ0
@GiulioConte @FraSantoroMD @marcovitoloMD @Dominik_Linz @DavideMei93 @AndyZhangMD @LuigiDiBiaseMD @ESC_Journals
0
12
20
“Age-adjusted natriuretic peptide thresholds for a diagnosis of heart failure in the community: diagnostic accuracy study.” Take a look at ESC Heart Failure👉 https://t.co/lTioTndyGj
#HFA_ESC #ESCHeartFailure @EJHFEiC @JanBiegus @Ppponikowski @hvanspall @ShelleyZieroth
1
115
302